Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kilgore

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|March 26, 1998
Response to salvage treatment in recurrent ovarian cancer treated initially with paclitaxel and platinum-based combination regimensP Y Roland, M N Barnes, S Niwas, et al.
Gynecologic Oncology|October 4, 2005
The use of adjuvant radiation therapy in patients with intermediate-risk Stages IC and II uterine corpus cancer: a patient care evaluation study from the American College of Surgeons National Cancer Data BaseJ Michael Straughn, T Michael Numnum, Larry C Kilgore, et al.
Clinical Biochemistry|March 24, 2009
Performance characteristics of a no-pretreatment, random access sirolimus assay for the Dimension RxL clinical chemistry systemMark A Cervinski, Show-Hong Duh, Karl G Hock, et al.
Applied and Environmental Microbiology|August 30, 2001
DNA from uncultured organisms as a source of 2,5-diketo-D-gluconic acid reductasesW H Eschenfeldt, L Stols, H Rosenbaum, et al.
Gynecologic Oncology|September 24, 2004
The impact of aborted radical hysterectomy in patients with cervical carcinomaCharles A Leath, J Michael Straughn, Jacob M Estes, et al.
The Oncologist|April 15, 2006
Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patientsRodney P Rocconi, J Michael Straughn, Charles A Leath, et al.
Surgery, Gynecology & Obstetrics|February 11, 1992
Effect of deoxyribonucleic acid ploidy status on survival of patients with carcinoma of the endometriumC H Dyas, T K Simmons, C N Ellis, et al.
Clinical Chemistry|June 29, 2002
Evaluation of a no-pretreatment cyclosporin A assay on the Dade Behring dimension RxL clinical chemistry analyzerAndrea R Terrell, Thomas M Daly, Karl G Hock, et al.
Gynecologic Oncology|October 6, 2009
Fixed-dose rate gemcitabine plus carboplatin in relapsed, platinum-sensitive ovarian cancer patients: results of a three-arm Phase I studyRonald D Alvarez, Robert Mannel, Agustin A García, et al.
Gynecologic Oncology|October 19, 2006
A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapyWhitney A Spannuth, Charles A Leath, Warner K Huh, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|March 26, 1998
Response to salvage treatment in recurrent ovarian cancer treated initially with paclitaxel and platinum-based combination regimensP Y Roland, M N Barnes, S Niwas, et al.
Gynecologic Oncology|October 4, 2005
The use of adjuvant radiation therapy in patients with intermediate-risk Stages IC and II uterine corpus cancer: a patient care evaluation study from the American College of Surgeons National Cancer Data BaseJ Michael Straughn, T Michael Numnum, Larry C Kilgore, et al.
Clinical Biochemistry|March 24, 2009
Performance characteristics of a no-pretreatment, random access sirolimus assay for the Dimension RxL clinical chemistry systemMark A Cervinski, Show-Hong Duh, Karl G Hock, et al.
Applied and Environmental Microbiology|August 30, 2001
DNA from uncultured organisms as a source of 2,5-diketo-D-gluconic acid reductasesW H Eschenfeldt, L Stols, H Rosenbaum, et al.
Gynecologic Oncology|September 24, 2004
The impact of aborted radical hysterectomy in patients with cervical carcinomaCharles A Leath, J Michael Straughn, Jacob M Estes, et al.
The Oncologist|April 15, 2006
Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patientsRodney P Rocconi, J Michael Straughn, Charles A Leath, et al.
Surgery, Gynecology & Obstetrics|February 11, 1992
Effect of deoxyribonucleic acid ploidy status on survival of patients with carcinoma of the endometriumC H Dyas, T K Simmons, C N Ellis, et al.
Clinical Chemistry|June 29, 2002
Evaluation of a no-pretreatment cyclosporin A assay on the Dade Behring dimension RxL clinical chemistry analyzerAndrea R Terrell, Thomas M Daly, Karl G Hock, et al.
Gynecologic Oncology|October 6, 2009
Fixed-dose rate gemcitabine plus carboplatin in relapsed, platinum-sensitive ovarian cancer patients: results of a three-arm Phase I studyRonald D Alvarez, Robert Mannel, Agustin A García, et al.
Gynecologic Oncology|October 19, 2006
A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapyWhitney A Spannuth, Charles A Leath, Warner K Huh, et al.
Pageof 7